CD4+ T-cell help amplifies innate signals for primary CD8+ T-cell immunity
Summary CD8+ T cells provide an important component of protection against intracellular infections and cancer. Immune responses by these T cells involve a primary phase of effector expansion and differentiation, followed by a contraction phase leading to memory formation and, if antigen is re‐encoun...
Saved in:
Published in | Immunological reviews Vol. 272; no. 1; pp. 52 - 64 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.07.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Summary
CD8+ T cells provide an important component of protection against intracellular infections and cancer. Immune responses by these T cells involve a primary phase of effector expansion and differentiation, followed by a contraction phase leading to memory formation and, if antigen is re‐encountered, a secondary expansion phase with more rapid differentiation. Both primary and secondary phases of CD8+ T‐cell immunity have been shown to depend on CD4+ T‐cell help, although during certain infections the primary phase is variable in this requirement. One explanation for such variability relates to the strength of associated inflammatory signals, with weak signals requiring help. Here, we focus on our studies that have dissected the requirements for help in the primary phase of the CTL response to herpes simplex virus, elucidating intricate interactions and communications between CD4+ T cells, various dendritic cell subsets, and CD8+ T cells. We place our studies in the context of others and describe a simple model of help where CD40 signaling amplifies innate signals to enable efficient CD8+ T‐cell expansion and differentiation. This model facilitates CTL induction to various different agents, without altering the qualitative innate signals that direct other important arms of immunity. |
---|---|
Bibliography: | National Health and Medical Research Council of Australia istex:DF48F8603BD55B8D53A6E0483BF0E7C60994C971 ark:/67375/WNG-ZQVPXD1V-L ArticleID:IMR12426 Australian Research Council ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 0105-2896 1600-065X |
DOI: | 10.1111/imr.12426 |